Jove
Visualize
Contact Us

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrostatic pressure regulates CYP1A2 expression in human hepatocytes via a mechanosensitive aryl hydrocarbon receptor-dependent pathway.

American journal of physiology. Cell physiology·2020
Same author

Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury.

Pharmacology & therapeutics·2017
Same author

Expression of drug transporters in human kidney: impact of sex, age, and ethnicity.

Biology of sex differences·2015
Same author

An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity.

Toxicological sciences : an official journal of the Society of Toxicology·2014
Same author

Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations.

Liver international : official journal of the International Association for the Study of the Liver·2014
Same author

Reducing attrition in drug development: smart loading preclinical safety assessment.

Drug discovery today·2013
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
Same journal

Which HTT transcript to lower?

Trends in pharmacological sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 16, 2026

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
10:44

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways

Published on: December 9, 2013

Gender differences in drug toxicity.

Tamara J Nicolson1, Howard R Mellor, Ruth R A Roberts

  • 1General Toxicology Sciences, Safety Assessment UK, AstraZeneca R&D, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK. Tamara.Nicolson@astrazeneca.com

Trends in Pharmacological Sciences
|February 2, 2010
PubMed
Summary
This summary is machine-generated.

Gender differences significantly impact drug efficacy and adverse drug reactions (ADRs). Understanding these sex-based variations, particularly hormonal influences, is crucial for personalized medicine and preventing drug attrition.

More Related Videos

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Related Experiment Videos

Last Updated: Jun 16, 2026

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
10:44

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways

Published on: December 9, 2013

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Area of Science:

  • Pharmacology
  • Toxicology
  • Endocrinology

Background:

  • Clinical data indicate emerging gender dimorphic profiles in drug efficacy and adverse drug reactions (ADRs).
  • Individualized therapies and preventing drug attrition necessitate understanding the molecular basis of gender-specific ADRs.
  • Variations in drug efficacy and toxicity are observed across various drug classes, including anesthetics, HIV-1 therapies, and antiarrhythmics.

Purpose of the Study:

  • To provide an overview of current understanding of gender-specific drug toxicity.
  • To present rational molecular explanations for observed gender-based adverse drug events.
  • To highlight the role of hormonal effects in sex-based differences in ADRs.

Main Methods:

  • Review of clinical data and existing literature on gender differences in drug response.
  • Analysis of factors contributing to pharmacokinetic and toxicity variations.
  • Exploration of molecular mechanisms, particularly hormonal influences.

Main Results:

  • Body weight differences alone do not fully explain gender-based variations in drug pharmacokinetics and toxicity.
  • Significant gender-based differences in drug efficacy and ADRs persist even after accounting for body weight.
  • Emerging evidence strongly supports hormonal effects as a primary driver for most observed sex-based ADR differences.

Conclusions:

  • Hormonal effects are a key molecular basis for gender dimorphic profiles in adverse drug reactions.
  • Understanding these sex-specific mechanisms is essential for advancing personalized medicine.
  • Further research into gender-specific drug toxicity can reduce drug attrition rates and improve patient outcomes.